Clinical Trials
3 trialsNCT01447914 2019-08-28
Tivantinib in Treating Patients With Relapsed, or Relapsed and Refractory Multiple Myeloma
National Cancer Institute (NCI)
Phase 2 Completed
NCT01817699 2019-02-04
CANDLE-KIT
CANDLE-KIT Trial Study Group
Phase 4 Terminated
NCT01105923 2015-02-02
MAPLE
Brigham and Women's Hospital
Phase NA Unknown